These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3122485)

  • 61. Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant.
    Mayumi T; Nagasawa K; Inoguchi T; Yamauchi Y; Ishii Y; Tada Y; Umeda F; Niho Y
    Ann Rheum Dis; 1991 Aug; 50(8):543-7. PubMed ID: 1909517
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Decreased fibrinolytic capacity and increased von Willebrand factor levels as indicators of endothelial cell dysfunction in patients with lupus anticoagulant.
    Nilsson TK; Löfvenberg E
    Clin Rheumatol; 1989 Mar; 8(1):58-63. PubMed ID: 2501064
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autoimmunity, fetal losses, lupus anticoagulant: beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression?
    Edelman P; Rouquette AM; Verdy E; Elias A; Cabane J; Cornet D; Barrat J; Chavinie J; Salat-Baroux J; Sureau C
    Hum Reprod; 1986 Aug; 1(5):295-7. PubMed ID: 3104398
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anticardiolipin syndrome in childhood: a report of two cases.
    Ravelli A; Caporali R; Bianchi E; Viola S; Solmi M; Montecucco C; Martini A
    Clin Exp Rheumatol; 1990; 8(1):95-8. PubMed ID: 2112074
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thrombosis in systemic lupus erythematosus: a French collaborative study.
    Montes de Oca MA; Babron MC; Blétry O; Broyer M; Courtecuisse V; Fontaine JL; Loirat C; Méry JP; Reinert P; Wechsler B
    Arch Dis Child; 1991 Jun; 66(6):713-7. PubMed ID: 1905123
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cutaneous manifestations associated with the presence of the lupus anticoagulant. A report of two cases and a review of the literature.
    Grob JJ; Bonerandi JJ
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):211-9. PubMed ID: 3091656
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients.
    Watson KV; Schorer AE
    Am J Med; 1991 Jan; 90(1):47-53. PubMed ID: 1898838
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pulmonary haemorrhage, pulmonary infarction, and the lupus anticoagulant.
    Howe HS; Boey ML; Fong KY; Feng PH
    Ann Rheum Dis; 1988 Oct; 47(10):869-72. PubMed ID: 3143319
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Lupus anticoagulants, thrombosis and accidental interruption of pregnancy].
    David JL
    Rev Med Liege; 1988 Nov; 43(22):737-40. PubMed ID: 3146791
    [No Abstract]   [Full Text] [Related]  

  • 70. Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks.
    Asherson RA; Gibson DG; Evans DW; Baguley E; Hughes GR
    Ann Rheum Dis; 1988 Nov; 47(11):947-53. PubMed ID: 3144942
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus.
    Averbuch M; Koifman B; Levo Y
    Am J Med Sci; 1987 Jan; 293(1):2-5. PubMed ID: 3101499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.
    Boey ML; Colaco CB; Gharavi AE; Elkon KB; Loizou S; Hughes GR
    Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1021-3. PubMed ID: 6412932
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Lupus anticoagulant and myocardial infarction in systemic lupus erythematosus with nephrotic syndrome: report of a case].
    Ikehara O; Hirata K; Uechi N; Asato H; Shiohira Y; Uehara H; Miyasato F
    Nihon Naika Gakkai Zasshi; 1987 Oct; 76(10):1612-3. PubMed ID: 3125290
    [No Abstract]   [Full Text] [Related]  

  • 74. Severe hemorrhage in a patient with circulating anticoagulant, acquired hypoprothrombinemia, and systemic lupus erythematosus.
    Small P
    Arthritis Rheum; 1988 Sep; 31(9):1210-1. PubMed ID: 3139005
    [No Abstract]   [Full Text] [Related]  

  • 75. The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.
    Cameron JS; Frampton G
    Pediatr Nephrol; 1990 Nov; 4(6):663-78. PubMed ID: 2128460
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lupus anticoagulant, anti-Ro (SS-A) antibodies, and fetal wastage in systemic lupus erythematosus.
    Hubscher O; Eimon A; Arana RM; Riveros DA
    Arthritis Rheum; 1988 Feb; 31(2):302-3. PubMed ID: 3126746
    [No Abstract]   [Full Text] [Related]  

  • 77. Superficial migratory thrombophlebitis and the lupus anticoagulant.
    Blum F; Gilkeson G; Greenberg C; Murray J
    Int J Dermatol; 1990 Apr; 29(3):190-2. PubMed ID: 2110553
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ischemic stroke in a girl with lupus anticoagulant.
    Kelley RE; Berger JR
    Pediatr Neurol; 1987; 3(1):58-61. PubMed ID: 3149470
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Lupus anticoagulant].
    Huang ZL
    Zhonghua Nei Ke Za Zhi; 1988 May; 27(5):318-21. PubMed ID: 3143524
    [No Abstract]   [Full Text] [Related]  

  • 80. Visual symptoms associated with the presence of a lupus anticoagulant.
    Levine SR; Crofts JW; Lesser GR; Floberg J; Welch KM
    Ophthalmology; 1988 May; 95(5):686-92. PubMed ID: 3140158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.